Garry A. Nicholson - Sep 12, 2022 Form 3 Insider Report for Day One Biopharmaceuticals, Inc. (DAWN)

Role
Director
Signature
/s/ By Charles N. York II, as Attorney-in-Fact for Reporting Person
Stock symbol
DAWN
Transactions as of
Sep 12, 2022
Transactions value $
$0
Form type
3
Date filed
9/14/2022, 07:32 PM
Previous filing
Aug 17, 2022
Next filing
Jun 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DAWN No securities beneficially owned. 0 Sep 12, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit 24.1 Power of Attorney